MRI of atherosclerosis: Diagnosis and monitoring therapy

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 1, 2007, Pages 69-80

  Anderson, Justin D ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Atherosclerosis; Atherosclerotic plaque; Magnetic resonance imaging; Vessel wall; Vulnerable plaque

Indexed keywords

ANTILIPEMIC AGENT; SIMVASTATIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGRAPHY; ANGIOSCOPY; AORTA ATHEROSCLEROSIS; ARTERY; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAUSE OF DEATH; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG DOSE COMPARISON; ECHOGRAPHY; HEART INFARCTION; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; REPRODUCIBILITY; REVIEW; RISK REDUCTION; THREE DIMENSIONAL IMAGING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; UNITED STATES;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MONITORING, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33846490165     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.1.69     Document Type: Review

References (86)

1. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, e85-e151 (2006).
2. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316, 1371-1375 (1987).
3. Davies MJ. Anatomic features in victims of sudden coronary death. Coronary artery pathology. Circulation 85, I19-I24 (1992).
4. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355-1374 (1995).
5. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262-1275 (2000).
6. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107, 2072-2075 (2003).
7. Libby P. Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
8. Shah PK. Pathophysiology of coronary thrombosis: Role of plaque rupture and plaque erosion. Prog. Cardiovasc. Dis. 44, 357-368 (2002).
9. Shah PK. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41, 15S-22S (2003).
10. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J. Vasc. Surg. 23, 755-765 (1996).
11. Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: Noninvasive MR characterization and identification of vulnerable lesions. Radiology 221, 285-299 (2001).
12. Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 105, 181-185 (2002).
13. Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107, 3047-3052 (2003).
14. Murphy RE, Moody AR, Morgan PS et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 107, 3053-3058 (2003).
15. Corti R, Fuster V, Badimon JJ, Hutter R, Fayad ZA. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann. N. Y. Acad. Sci. 947, 181-195 (2001).
16. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 108, 1664-1672 (2003).
17. Becker CR, Nikolaou K, Muders M et al. Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT. Eur. Radiol. 13, 2094-2098 (2003).
18. Hausleiter J, Meyer T, Hadamitzky M et al. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J. Am. Coll. Cardiol. 48, 312-318 (2006).
19. Pasterkamp G, Falk E, Woutman H, Borst C. Techniques characterizing the coronary atherosclerotic plaque: Influence on clinical decision making? J. Am. Coll. Cardiol. 36, 13-21 (2000).
20. Yuan C, Kerwin WS. MRI of atherosclerosis. J. Magn. Reson. Imaging. 19, 710-719 (2004).
21. Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 12, 56-62 (1988).
22. Little WC, Constantinescu M, Applegate RJ et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78, 1157-1166 (1988).
23. Rose SC, Nelson TR. Ultrasonographic modalities to assess vascular anatomy and disease. J. Vasc. Interv. Radiol. 15, 25-38 (2004).
24. Fosse E, Johnsen SH, Stensland-Bugge E et al. Repeated visual and computer-assisted carotid plaque characterization in a longitudinal population-based ultrasound study: The Tromso study. Ultrasound Med. Biol. 32, 3-11 (2006).
25. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 104, 68-73 (2001).
26. Schminke U, Hilker L, Motsch L, Griewing B, Kessler C. Volumetric assessment of plaque progression with 3-dimensional ultrasonography under statin therapy. J. Neuroimaging. 12, 245-251 (2002).
27. Spagnoli LG, Mauriello A, Sangiorgi G et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292, 1845-1852 (2004).
28. Komiyama N, Berry GJ, Kolz ML et al. Tissue characterization of atherosclerotic plaques by intravascular ultrasound radiofrequency signal analysis: An in vitro study of human coronary arteries. Am. Heart J. 140, 565-574 (2000).
29. Nair A, Kuban BD, Tuzcu EM et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106, 2200-2206 (2002).
30. Nissen SE, Yock P. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 103, 604-616 (2001).
31. Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J. Am. Coll. Cardiol. 46, 2038-2042 (2005).
32. Rodriguez-Granillo GA, Garcia-Garcia HM, Valgimigli M et al. Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofrequency data analysis. Eur. Heart J. 27, 1921-1927 (2006).
33. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK: Intravascular modalities for detection of vulnerable plaque: Current status. Arterioscler. Thromb. Vasc. Biol. 23, 1333-1342 (2003).
34. Toussaint JF, Southern JF, Fuster V, Kantor HL. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1533-1542 (1995).
35. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 94, 932-938 (1996).
36. Yuan C, Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104, 2051-2056 (2001).
37. Fayad ZA, Nahar T, Fallon JT et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: A comparison with transesophageal echocardiography. Circulation 101, 2503-2509 (2000).
38. Kramer CM, Cerilli LA, Hagspiel K et al. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation 109, 1016-1021 (2004).
39. Isbell DC, Meyer CH, Rogers WJ et al. Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with magnetic resonance imaging. J. Cardiovasc. Magn. Reson. (2007) (In Press).
40. Botnar RM, Stuber M, Kissinger KV et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 102, 2582-2587 (2000).
41. Fayad ZA, Fuster V, Fallon JT et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102, 506-510 (2000).
42. Kang X, Polissar NL, Han C, Lin E, Yuan C. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn. Reson. Med. 44, 968-972 (2000).
43. Yuan C, Beach KW, Smith LH Jr, Hatsukami TS. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 98, 2666-2671 (1998).
44. Cai J, Hatsukami TS, Ferguson MS et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: Comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112, 3437-3444 (2005).
45. Mitsumori LM, Hatsukami TS, Ferguson MS et al. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J. Magn. Reson. Imaging. 17, 410-420 (2003).
46. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102, 959-964 (2000).
47. Chan SK, Jaffer FA, Botnar RM et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J. Cardiovasc. Magn. Reson. 3, 331-338 (2001).
48. Coulden RA, Moss H, Graves MJ et al. High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty. Heart 83, 188-191 (2000).
49. Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: A meta-anaiysis. J. Am. Coll. Cardiol. 44, 1867-1876 (2004).
50. Kim WY, Stuber M, Bornert P et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106, 296-299 (2002).
51. Desai MY, Lai S, Barnet C, Weiss RG, Stuber M. Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur. Heart J. 26, 2320-2324 (2005).
52. Maintz D, Ozgun M, Hoffmeier A et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur. Heart J. 27, 1732-1736 (2006).
53. Leiner T, Gerretsen S, Botnar R et al. Magnetic resonance imaging of atherosclerosis. Eur. Radiol. 15, 1087-1099 (2005).
54. Brown BG, Zhao XQ, Chait A et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345, 1583-1592 (2001).
55. Cashin-Hemphill L, Mack WJ, Pagoda JM et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA 264, 3013-3017 (1990).
56. Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280, 2001-2007 (1998).
57. Taylor A, Shaw LJ, Fayad Z et al. Tracking atherosclerosis regression: A clinical tool in preventive cardiology. Atherosclerosis 180, 1-10 (2005).
58. Nissen SE, Tuzcu EM, Libby P et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: TheACAMELOT study: a randomized controlled trial. JAMA 292, 2217-2225 (2004).
59. Nissen SE. Effect of intensive lipid lowering on progression of coronary atherosclerosis: Evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am. J. Cardiol. 96, 61F-68F (2005).
60. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 295, 1556-1565 (2006).
61. Zhao XQ, Yuan C, Hatsukami TS et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study. Arterioscler. Thromb. Vasc. Biol. 21, 1623-1629 (2001).
62. Corti R, Fayad ZA, Fuster V et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104, 249-252 (2001).
63. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106, 2884-2887 (2002).
64. Corti R, Fuster V, Fayad ZA et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: A prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46, 106-112 (2005).
65. Lima JA, Desai MY, Steen H et al. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110, 2336-2341 (2004).
66. Yonemura A, Momiyama Y, Fayad ZA et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J. Am. Coll. Cardiol. 45, 733-742 (2005).
67. Berg A, Sailer J, Rand T, Moser E. Diffusivity- and T2 imaging at 3 Tesla for the detection of degenerative changes in human-excised tissue with high resolution: Atherosclerotic arteries. Invest. Radiol. 38, 452-459 (2003).
68. Botnar RM, Stuber M. Lamerichs R et al. Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla. J. Cardiovasc. Magn. Reson. 5, 589-594 (2003).
69. Nahrendorf M, Jaffer FA, Kelly KA et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114, 1504-1511 (2006).
70. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415-422 (2001).
71. Kooi ME, Cappendijk VC, Cleutjens KB et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453-2458 (2003).
72. Tang T, Howarth SP, Miller SR et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37, 2266-2270 (2006).
73. Trivedi RA, Mallawarachi C, King-Im JM et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26, 1601-1606 (2006).
74. Botnar RM, Perez AS, Witte S et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109, 2023-2029 (2004).
75. Botnar RM, Buecker A, Wiethoff AJ et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 110, 1463-1466 (2004).
76. Sirol M, Itskovich VV, Mani V et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 109, 2890-2896 (2004).
77. Nazarian S, Roguin A, Zviman MM et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 114, 1277-1284 (2006).
78. Sommer T, Naehle CP, Yang A et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: A prospective study with 115 examinations. Circulation 114, 1285-1292 (2006).
79. Liu F, Xu D, Ferguson MS et al. Automated in vivo segmentation of carotid plaque MRI with Morphology-Enhanced probability maps. Magn. Reson. Med. 55, 659-668 (2006).
80. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: A prospective assessment with MRI - initial results. Stroke 37, 818-823 (2006).
81. Choi CJ, Kramer CM. MR imaging of atherosclerotic plaque. Radiol. Clin. North Am. 40, 887-898 (2002).
82. Schneiderman J, Wilensky RL, Weiss A et al. Diagnosis of thin-cap fibroatheromas by a self-contained intravascular magnetic resonance imaging probe in ex vivo human aortas and in situ coronary arteries. J. Am. Coll. Cardiol. 45, 1961-1969 (2005).
83. Rogers WJ, Prichard JW, Hu YL et al. Characterization of signal properties in atherosclerotic plaque components by intravascular MRI. Arterioscler. Thromb. Vasc. Biol. 20, 1824-1830 (2000).
84. Larose E, Yeghiazarians Y, Libby P et al. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation 112, 2324-2331 (2005).
85. Wilensky RL, Song HK, Ferrari VA. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J. Am. Coll. Cardiol. 47, C48-C56 (2006).
86. Hillenbrand CM, Jesberger JA, Wong EY et al. Toward rapid high resolution in vivo intravascular MRI: Evaluation of vessel wall conspicuity in a porcine model using multiple imaging protocols. J. Magn. Reson. Imaging. 23, 135-144 (2006).